Advertisement

Topics

Lakewood-Amedex Inc. Company Profile

14:05 EDT 20th September 2017 | BioPortfolio

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas and others, and patents covering certain proprietary products targeting pandemic viral infections including Epstein Barr Virus (EBV), human and avian influenza, Hepatitis B and C and other clinical indications. The Company anticipates initiating human clinical trials for topical use of its Nu-3 NuBiotics compound in the near future for indications including diabetic ulcers and other topical infections. Future studies will involve the use of Nu-2 to treat broad spectrum antibiotic-resistant bacterial pulmonary and systemic infections. The company is currently conducting a human IRB clinical study to improve treatment of nasopharyngeal carcinoma in Changsha, China. Lakewood-Amedex is headquartered in Sarasota, FL.


News Articles [27 Associated News Articles listed on BioPortfolio]

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment For Final Cohort Of The Company's Phase I/IIa Program In Patients With Infected Diabetic Foot Ulcers

  Life Sciences Jobs   ...

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's ...

"Although this remains a blinded study, we are hopeful that the top line data in this Phase 1/2a study for Nu-3 will show similar results Read more...

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers Top Line Results Expected in September 201...

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company's Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers

SARASOTA, Fla., Aug. 22, 2017 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today the completion of patient treatment in the final c...

NJ millionaires-on-welfare ‘stealing’ from poor, fmr. Lakewood mayor says

More than two-dozen individuals in Lakewood, N.J. have been charged with swindling the government out of about $2.4 million in unmerited public assistance benefits — an alleged crime the town's for...

Lakewood-Amedex Inc. Strengthens Board of Directors with Two Industry Veterans

SARASOTA, Fla., Aug. 31, 2017 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that Neil J. Campbell, MA, MBA, and Leonard DeRoma...

Hurricane Harvey: Texas' biggest church 'closes doors' during Hurricane Harvey

A megachurch in Houston closed its doors in the aftermath of Hurricane Harvey, which has caused catastrophic flooding and forced thousands to leave their homes. An announcement on Facebook said Pasto...

Joel Osteen responds to Criticism Over Lakewood Church’s Flood Response

"The church has always been open."

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Acd [CaridianBCT, Inc.]

Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A 750 ml

Nitrogen [Airgas-West, Inc.]

nitrogen

As [CaridianBCT, Inc.]

Additive Solution Formula 3

Air [Airgas-West, Inc.]

air

Rezil [Toqara, Inc.]

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [16 Associated Companies listed on BioPortfolio]

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications cove...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications cove...

Lakewood Pathology Associates

Lakewood Pathology Associates (LPA) is a national anatomical pathology company providing comprehensive and dynamic pathology services tailored to the outpatient needs of surgeons of diverse specialtie...

Lakewood Regional Medical Center

Worthington Biochemical Corporation

Worthington Biochemical Corporation produces and manufactures biochemicals, specifically enzymes.

More Information about "Lakewood-Amedex Inc." on BioPortfolio

We have published hundreds of Lakewood-Amedex Inc. news stories on BioPortfolio along with dozens of Lakewood-Amedex Inc. Clinical Trials and PubMed Articles about Lakewood-Amedex Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lakewood-Amedex Inc. Companies in our database. You can also find out about relevant Lakewood-Amedex Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record